139
Views
11
CrossRef citations to date
0
Altmetric
Original Research

Clinical Characteristics And Risk Factors In Mixed-Enterococcal Bloodstream Infections

, , , , , , ORCID Icon, , , , , ORCID Icon, , & show all
Pages 3397-3407 | Published online: 31 Oct 2019

References

  • Rodriguez-Creixems M, Alcala L, Munoz P, Cercenado E, Vicente T, Bouza E. Bloodstream infections: evolution and trends in the microbiology workload, incidence, and etiology, 1985–2006. Medicine (Baltimore). 2008;87(4):234–249.18626306
  • Worth LJ, Spelman T, Bull AL, Brett JA, Richards MJ. Central line-associated bloodstream infections in Australian intensive care units: time-trends in infection rates, etiology, and antimicrobial resistance using a comprehensive Victorian surveillance program, 2009–2013. Am J Infect Control. 2015;43(8):848–852. doi:10.1016/j.ajic.2015.03.03626026826
  • Weiner LM, Webb AK, Limbago B, et al. Antimicrobial-resistant pathogens associated with healthcare-associated infections: summary of data reported to the national healthcare safety network at the centers for disease control and prevention, 2011–2014. Infect Control Hosp Epidemiol. 2016;37(11):1288–1301. doi:10.1017/ice.2016.17427573805
  • Treitman AN, Yarnold PR, Warren J, Noskin GA. Emerging incidence of enterococcus faecium among hospital isolates (1993 to 2002). J Clin Microbiol. 2005;43(1):462–463. doi:10.1128/JCM.43.1.462-463.200515635016
  • Pinholt M, Ostergaard C, Arpi M, et al. Incidence, clinical characteristics and 30-day mortality of enterococcal bacteraemia in Denmark 2006–2009: a population-based cohort study. Clin Microbiol Infect. 2014;20(2):145–151. doi:10.1111/1469-0691.1223623647880
  • Noskin GA, Peterson LR, Warren JR. Enterococcus faecium and enterococcus faecalis bacteremia: acquisition and outcome. Clin Infect Dis. 1995;20(2):296–301. doi:10.1093/clinids/20.2.2967742433
  • Lodise TP, McKinnon PS, Tam VH, Rybak MJ. Clinical outcomes for patients with bacteremia caused by vancomycin-resistant enterococcus in a level 1 trauma center. Clin Infect Dis. 2002;34(7):922–929. doi:10.1086/33921111880957
  • DiazGranados CA, Zimmer SM, Klein M, Jernigan JA. Comparison of mortality associated with vancomycin-resistant and vancomycin-susceptible enterococcal bloodstream infections: a meta-analysis. Clin Infect Dis. 2005;41(3):327–333. doi:10.1086/43090916007529
  • Billington EO, Phang SH, Gregson DB, et al. Incidence, risk factors, and outcomes for Enterococcus spp. blood stream infections: a population-based study. Int J Infect Dis. 2014;26:76–82. doi:10.1016/j.ijid.2014.02.01224813873
  • Zhang Y, Du M, Chang Y, Chen LA, Zhang Q. Incidence, clinical characteristics, and outcomes of nosocomial Enterococcus spp. bloodstream infections in a tertiary-care hospital in Beijing, China: a four-year retrospective study. Antimicrob Resist Infect Control. 2017;6:73. doi:10.1186/s13756-017-0231-y28680588
  • Cheah AL, Spelman T, Liew D, et al. Enterococcal bacteraemia: factors influencing mortality, length of stay and costs of hospitalization. Clin Microbiol Infect. 2013;19(4):E181–E189. doi:10.1111/1469-0691.1213223398607
  • Weinstein MP, Towns ML, Quartey SM, et al. The clinical significance of positive blood cultures in the 1990s: a prospective comprehensive evaluation of the microbiology, epidemiology, and outcome of bacteremia and fungemia in adults. Clin Infect Dis. 1997;24(4):584–602. doi:10.1093/clind/24.4.5849145732
  • Wisplinghoff H, Bischoff T, Tallent SM, Seifert H, Wenzel RP, Edmond MB. Nosocomial bloodstream infections in US hospitals: analysis of 24,179 cases from a prospective nationwide surveillance study. Clin Infect Dis. 2004;39(3):309–317. doi:10.1086/42194615306996
  • Lin JN, Lai CH, Chen YH, et al. Characteristics and outcomes of polymicrobial bloodstream infections in the emergency department: A matched case-control study. Acad Emerg Med. 2010;17(10):1072–1079. doi:10.1111/j.1553-2712.2010.00871.x21040108
  • Weinstein MP, Reller LB, Murphy JR. Clinical importance of polymicrobial bacteremia. Diagn Microbiol Infect Dis. 1986;5(3):185–196. doi:10.1016/0732-8893(86)90001-53757473
  • Pavlaki M, Poulakou G, Drimousis P, et al. Polymicrobial bloodstream infections: epidemiology and impact on mortality. J Glob Antimicrob Resist. 2013;1(4):207–212. doi:10.1016/j.jgar.2013.06.00527873614
  • Sancho S, Artero A, Zaragoza R, Camarena JJ, Gonzalez R, Nogueira JM. Impact of nosocomial polymicrobial bloodstream infections on the outcome in critically ill patients. Eur J Clin Microbiol Infect Dis. 2012;31(8):1791–1796. doi:10.1007/s10096-011-1503-822167257
  • Lagnf AM, Zasowski EJ, Claeys KC, Casapao AM, Rybak MJ. Comparison of clinical outcomes and risk factors in polymicrobial versus monomicrobial enterococcal bloodstream infections. Am J Infect Control. 2016;44(8):917–921. doi:10.1016/j.ajic.2016.02.01727079241
  • Bloodstream Infection (BSI) Events. Centers for Disease Control and Prevention. Available from: https://www.cdc.gov/nhsn/PDFs/pscManual/4PSC_CLABScurrent.pdf Accessed 12019.
  • Garner JS, Jarvis WR, Emori TG, Horan TC, Hughes JM. CDC definitions for nosocomial infections, 1988. American journal of infection control 1988;16(3):128–140.
  • Suzuki H, Hase R, Otsuka Y, Hosokawa N. A 10-year profile of enterococcal bloodstream infections at a tertiary-care hospital in Japan. J Infect Chemother. 2017;23(6):390–393. doi:10.1016/j.jiac.2017.03.00928385565
  • Zasowski EJ, Claeys KC, Lagnf AM, Davis SL, Rybak MJ. Time is of the essence: the impact of delayed antibiotic therapy on patient outcomes in hospital-onset enterococcal bloodstream infections. Clin Infect Dis. 2016;62(10):1242–1250. doi:10.1093/cid/ciw11026945013
  • Singer M, Deutschman CS, Seymour CW, et al. The third international consensus definitions for sepsis and septic shock (sepsis-3). JAMA. 2016;315(8):801–810. doi:10.1001/jama.2016.028726903338
  • Lautenbach E, Bilker WB, Brennan PJ. Enterococcal bacteremia: risk factors for vancomycin resistance and predictors of mortality. Infect Control Hosp Epidemiol. 1999;20(5):318–323. doi:10.1086/50162410349947
  • Bouza E, Burillo A, Munoz P, Guinea J, Marin M, Rodriguez-Creixems M. Mixed bloodstream infections involving bacteria and Candida spp. J Antimicrob Chemother. 2013;68(8):1881–1888. doi:10.1093/jac/dkt09923535881
  • Hamada Y, Magarifuchi H, Oho M, et al. Clinical features of enterococcal bacteremia due to ampicillin-susceptible and ampicillin-resistant enterococci: an eight-year retrospective comparison study. J Infect Chemother. 2015;21(7):527–530. doi:10.1016/j.jiac.2015.04.00125935477
  • Weisser M, Capaul S, Dangel M, et al. Additive effect of enterococcus faecium on enterococcal bloodstream infections: a 14-year study in a Swiss tertiary hospital. Infect Control Hosp Epidemiol. 2013;34(10):1109–1112. doi:10.1086/67314524018931
  • Zhao C, Chen H, Wang H, et al. [Analysis of pathogen spectrum and resistance of clinical common organisms causing bloodstream infections, hospital-acquired pneumonia and intra-abdominal infections from thirteen teaching hospitals in 2013]. Zhonghua Yi Xue Za Zhi. 2015;95(22):1739–1746.26704158
  • Cattoir V, Giard JC. Antibiotic resistance in enterococcus faecium clinical isolates. Expert Rev Anti Infect Ther. 2014;12(2):239–248. doi:10.1586/14787210.2014.87088624392717
  • Nallapareddy SR, Singh KV, Murray BE. Contribution of the collagen adhesin Acm to pathogenesis of Enterococcus faecium in experimental endocarditis. Infect Immun. 2008;76(9):4120–4128. doi:10.1128/IAI.00376-0818591236
  • Pammi M, Zhong D, Johnson Y, Revell P, Versalovic J. Polymicrobial bloodstream infections in the neonatal intensive care unit are associated with increased mortality: a case-control study. BMC Infect Dis. 2014;14:390. doi:10.1186/1471-2334-14-39025022748
  • Kim SH, Yoon YK, Kim MJ, Sohn JW. Risk factors for and clinical implications of mixed Candida/bacterial bloodstream infections. Clin Microbiol Infect. 2013;19(1):62–68. doi:10.1111/j.1469-0691.2012.03906.x22651822
  • Reuben AG, Musher DM, Hamill RJ, Broucke I. Polymicrobial bacteremia: clinical and microbiologic patterns. Rev Infect Dis. 1989;11(2):161–183. doi:10.1093/clinids/11.2.1612649955
  • Quach S, Hennessy DA, Faris P, Fong A, Quan H, Doig C. A comparison between the APACHE II and Charlson Index Score for predicting hospital mortality in critically ill patients. BMC Health Serv Res. 2009;9:129. doi:10.1186/1472-6963-9-12919643010
  • Zorgani A, Franka RA, Zaidi MM, Alshweref UM, Elgmati M. Trends in nosocomial bloodstream infections in a burn intensive care unit: an eight-year survey. Ann Burns Fire Disasters. 2010;23(2):88–94.21991204
  • Sato A, Nakamura I, Fujita H, et al. Peripheral venous catheter-related bloodstream infection is associated with severe complications and potential death: a retrospective observational study. BMC Infect Dis. 2017;17(1):434. doi:10.1186/s12879-017-2757-228623882
  • Saliba P, Hornero A, Cuervo G, et al. Mortality risk factors among non-ICU patients with nosocomial vascular catheter-related bloodstream infections: a prospective cohort study. J Hosp Infect. 2018;99(1):48–54. doi:10.1016/j.jhin.2017.11.00229128346
  • Saliba P, Hornero A, Cuervo G, et al. Interventions to decrease short-term peripheral venous catheter-related bloodstream infections: impact on incidence and mortality. J Hosp Infect. 2018;100(3): e178-e186. doi:10.1016/j.jhin.2018.06.010
  • Pan S, Huang X, Wang Y, et al. Efficacy of intravenous plus intrathecal/intracerebral ventricle injection of polymyxin B for post-neurosurgical intracranial infections due to MDR/XDR Acinectobacter baumannii: a retrospective cohort study. Antimicrob Resist Infect Control. 2018;7:8. doi:10.1186/s13756-018-0305-529387342
  • Yu Y, Li XX, Jiang LX, et al. Procalcitonin levels in patients with positive blood culture, positive body fluid culture, sepsis, and severe sepsis: a cross-sectional study. Infect Dis (Lond). 2016;48(1):63–69. doi:10.3109/23744235.2015.108261826337821
  • Charles PE, Ladoire S, Aho S, et al. Serum procalcitonin elevation in critically ill patients at the onset of bacteremia caused by either Gram negative or Gram positive bacteria. BMC Infect Dis. 2008;8:38. doi:10.1186/1471-2334-8-3818366777
  • Leli C, Ferranti M, Moretti A, Al Dhahab ZS, Cenci E, Mencacci A. Procalcitonin levels in gram-positive, gram-negative, and fungal bloodstream infections. Dis Markers. 2015;2015:701480. doi:10.1155/2015/10535825852221
  • Renaud B, Brun-Buisson C. Outcomes of primary and catheter-related bacteremia. A cohort and case-control study in critically ill patients. Am J Respir Crit Care Med. 2001;163(7):1584–1590. doi:10.1164/ajrccm.163.7.991208011401878